Maintaining Work During Dialysis Tied to Higher Survival
FRIDAY, June 21, 2019 -- Working in the six months before initiating hemodialysis (HD) is associated with better survival, according to a large study published online June 14 in the Clinical Kidney Journal.
Yuxin Nie, from Fudan University in Shanghai, and colleagues assessed employment (full-time or part-time) for 496,989 patients initiating maintenance HD from 2006 to 2015. The relationships between patient and dialysis facility characteristics and employment were explored.
The researchers found that 26 percent of patients were employed six months prior to HD initiation compared with 15 percent at HD initiation. Pre-HD initiation employment decreased from 29 percent in 2006 to 23 percent in 2014. The percentage of employed patients who maintained employment increased from 57 percent in 2006 to 64 percent in 2015. Maintaining employment was less likely among patients who were older, female, Hispanic, or black, those with more comorbidities, and those living in low-income zip codes. Employment maintenance was associated with the facilities that held nonprofit status, more stations, dialysis availability after 5 p.m., and home dialysis training. Mortality was lower and transplantation rates were higher among patients who maintained employment during the six months prior to HD compared with patients who became unemployed.
"We should further strengthen peritoneal dialysis as well as home hemodialysis, which are often better dialysis modalities for patients who want to continue working," Alberto Ortiz, M.D., Ph.D., editor-in-chief of the Clinical Kidney Journal, said in a statement.
© 2020 HealthDay. All rights reserved.
Posted: June 2019
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.